ABSTRACT-The traditional approach to the study of biology employs small-scale experimentation that results in the description of a molecular sequence of known function or relevance. In the era of the genome the reverse is true, as large-scale cloning and gene sequencing come first, followed by the use of computational methods to systematically determine gene function and regulation. The overarching goal of this new approach is to translate the knowledge learned from a systematic, global analysis of genomic data into a complete understanding of biology. For investigators who study shock, the specific goal is to increase understanding of the adaptive response to injury at the level of the entire genome. This review describes our initial experience using DNA microarrays to profile stress-induced changes in gene expression. We conclude that efforts to apply genomics to the study of injury are best coordinated by multi-disciplinary groups, because of the extensive expertise required.
"The best way to predict the future is to invent it." Alan Kay (1971)
The traditional approach to the study of biology employs small-scale experimentation that results in the description of a molecular sequence of known function or relevance (the hypothesis-driven, "single gene" approach). In the era of the genome the reverse is true, as large-scale cloning and gene sequencing come first, followed by the use of computational methods to systematically determine gene function and regulation (the systematic, "discovery"-, or "question"-driven approach, Table 1 ). Genomics, then, can be defined as the use of strategies to understand "the inherent order of biology" at the molecular level using massive parallel techniques (1) . Functional genomics seeks to determine, in a physiological or clinical context, the significance of the observed changes in gene expression. The overarching goal of this new approach is to translate the knowledge learned from a systematic, global analysis of genomic data into a complete understanding of cellular physiology. For investigators who study shock, therefore, the specific goal is to increase understanding of the adaptive response to injury at the level of the entire genome.
This strategy is fundamentally different from that which has been applied previously. Not unexpectedly, it has met early with substantial criticism as did its investigative parent, the Human Genome Project, another so-called "fishing expedition"* (2) . In particular, the genomic ("systematic") approach is not an attempt to "identify the gene" that is responsible for a given response. Rather, it seeks to paint a complete, molecular "portrait of life," identifying the activity of all genes by utilizing breakthrough technological developments to monitor changes in gene transcription and translation (1) . These new tools provide an unprecedented opportunity to "observe the living genome" (see "Technology") (1).
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*"Beyond semantics, -omic research appears to require a different mind-set from the more traditional study of one gene, gene product, or process at a time. Often, one generates a database of molecular information with only limited ability to predict what about it will prove most useful. A 1984 position paper on sequencing the genome offered the candid opinion that:
'In some respects, like the journeys to the moon, it is simply a "tour de force"; it is not at all clear that knowledge of the nucleotide sequence of the human genome will, initially, provide deep insights into the physical nature of man. Nevertheless, we are confident that this project will provide an integrating focus for all efforts to use DNA cloning techniques in the study of human genetics. ' Despite obvious excitement about the genome project, some referees, editors, site visitors, and study sections have tended to disparage other -omic studies as "fishing expeditions"-often because the hypothesis that drives the generation of a molecular database relates to the nature of information and its utility, rather than to biological specifics. That bias has been dissipating (although not rapidly enough) because of the growing realization that we will have to understand our favorite biological molecules in the context of many thousands of others and that a wide net must be cast to be sure that we have, in fact, found the important ones. In line with a point made by Hieter and Boguski [Science 278: 601-2, 1997], -omic research should be viewed as synergistic with the more traditional studies of single molecules. The two approaches to science require similar creativity, judgment, and technical rigor. If one is going to fish, it is best to do so in teeming waters with the finest equipment and flawless technique." JN Weinstein, NCI, NIH, Bethesda, MD (2)
INVESTIGATIVE STRATEGY
The central dogma of molecular biology states that DNA makes RNA makes protein (Fig. 1) . The goal of a genome project is to map and sequence the DNA of an organism. In contrast, the goal of functional genomics is to describe an infinitely more dynamic process, namely the regulatory relationships between genes and their programs of expression, as reflected by changes in mRNA abundance and protein levels (the transcriptome and proteome, respectively) (3). In multicellular organisms, individual cellular responses are integrated at the organ and host levels (the physiome and biome). These relationships are depicted in Figure 1 . A molecular profile of a given tissue at a specified time point, then, includes a complete characterization of the genome, the transcriptome and the proteome, in concert with an understanding of their regulatory interdependence as manifested in the physiome and biome. The tools necessary to take this "snapshot" with resolution at the molecular level have not been available previously. However, recent technical advances in miniaturization, robotics, manufacturing, and processing have made the application of this strategy a reality (4) .
An example taken from another group of investigators who study injury in a different species, Saccharomyces cerevisiae, will help to illustrate the power of this approach. The complete genome of this yeast was reported in 1996 (5). Gene expression data including 25 physiologically different conditions were assayed, simultaneously, measuring mRNA levels for each of the 5,885 genes in the genome (∼2.4 million data points from 400 microarray hybridizations) (6) . Analysis indicated that stress stimuli as diverse as changes in temperature or osmolarity, starvation, radiation, deformation, and reactive oxygen species each induced similar changes in the expression of a large number of genes, subsequently called the "common stress response" (CSR) cluster. Fully 50% of these genes are of unknown function, but appear to be important to the yeast adaptive response to stress (6) . Analysis of the upstream regions (e.g., 300 bp) in such clusters using pattern discovery algorithms that search exhaustively for a priori unknown, over-represented sequences yielded several putative transcription factor-binding sites (7) . Most had matches to substrings of previously identified yeast transcription-binding sites. Moreover, several of them are already known to be important for gene expression in response to the respective stimulus. Is there a mammalian (human) homolog to the yeast CSR cluster? Or have multicellular organisms such as humans developed more specialized and specific adaptive responses to stress, likely integrated at the cellular, organ, and host level? These questions are answerable with available technology and developing expertise.
TECHNOLOGY
As described above, recent technological breakthroughs have made it possible to affix thousands of DNA elements ("spots" or "probes") onto a single matrix (typically nylon or glass) (4) . By hybridizing these "microarrays" with a labeled cDNA or cRNA "target" derived from the cells or tissue of interest, relative mRNA abundance can be determined in a highly parallel fashion. With the aid of a template describing the unique location of each probe on the microarray, computerdriven differential analysis can be used to measure the binding of target to probe, and to subsequently determine changes in gene expression (either up or down) relative to a standard (control) (8) . This strategy can be used to describe changes in gene expression over time or between samples.
If the ability of microarrays to profile tens of thousands of genes simultaneously is its most impressive feature, then its biggest potential pitfall is the difficulty of ensuring high fidelity, reproducible DNA hybridization over the huge number of elements that cover the array. Thus, ongoing quality assessment and control are vital components of each step in any microarray project, including fabrication of the microarray, preparation and labeling of the target, hybridization of target and probe, and data extraction from the microarray image (9) . While an exhaustive discussion is beyond the scope of this review, many of these potential sources of technical error are listed in Table 2 . Inclusion of numerous internal controls is required, which significantly improves confidence in the quality of the microarray data. Moreover, the importance of replication in microarray gene expression profiling studies has been documented (10) . Thus, the ideal microarray is high throughput, specific, sensitive, reproducible, and at least semiquantitative. In addition, it should detect the rarest mRNA's with the fewest sample manipulations, keeping false-negatives and false-positives to an absolute minimum. While no microarray perfectly fulfills all of these criteria, recent reports have validated the cost-effectiveness of many commercially available products (11) .
Two types of DNA microarrays are used commonly: spotted and in situ synthesized microarrays. The former are produced by spotting scores to thousands of probe cDNA products specific for the genes of interest onto a nylon or glass matrix. In contrast, in situ synthesized microarrays are produced using directed probe synthesis (e.g., photolithography) on the matrix to create several hundred thousand 20 to 25 mer probe oligonucleotide elements (4). The major advantage of the smaller cDNA microarrays is customization and relatively low cost, whereas the more comprehensive, standardized oligonucleotide microarrays provide maximal opportunities for genomewide screening, but at a substantially increased price (Table 3) . Typically, broad-scale changes in gene expression are performed on microarrays that contain thousands of gene elements to screen for gene groups or "clusters" that appear to be expressed similarly (12) . The biostatistical methods used to probe data sets of this size (millions of data points) are novel and complex (13) . A common cost-effective strategy, therefore, is to use the higher-priced screening arrays to identify potentially informational gene sets, and then use these sets to make the smaller, less expensive custom microarrays to investigate more exhaustively. † Because there is a small, but real, chance of identifying false-positive or false-negative changes in mRNA abundance (typically rates of 2%-5% are mentioned), (14) validation of these potentially informational changes in gene expression (transcriptome) are critical. This can be performed using conventional molecular strategies including northern blot or RT-PCR analysis, as well as newer complementary techniques such as real-time "quantitative" PCR (RTQ-PCR) (15) . In brief, RTQ-PCR consists of standard PCR used in conjunction with a fluorogenic probe; the intensity of fluorescence is then proportional to the amount of target DNA present. The advantages of RTQ-PCR are that it provides accurate and reproducible quantitation of gene copies, it has a large dynamic range, and it is relatively cheap and less labor-intensive than other quantitative PCR methods. The disadvantages of this approach are that it is relatively low-throughput and the start up cost (equipment), as with microarrays, is expensive.
THE PROMISE OF GENOMICS
The exciting potential of genomics can readily be seen in the following example. Two patients recently were admitted to the Trauma Service at the Washington University Medical Center in St. Louis. Both were previously healthy young men who sustained injury as a result of blunt trauma. Both of them had splenectomies during their hospitalizations. The first patient's spleen was removed the day of injury because of splenic trauma associated with hemorrhage, but without shock (considered as "control"). In contrast, the spleen of the second patient, a victim of severe polysystem trauma, was removed after 4 weeks of hospitalization characterized by severe shock, sepsis, and multiple organ dysfunction syndrome (MODS) that ultimately culminated in death. In accordance with an investigational review board-approved protocol, small specimens from each spleen were obtained and frozen in the operating room immediately before they were sent to pathology. The demographics and results of laboratory investigations from these two specimens are compared in Table 4 .
In the spleen from the patient 1 (injury without MODS), the splenic tissue was normal except for gross evidence of mechanical trauma resulting in hemorrhage. In contrast, the splenic tissue from patient 2 (injury with MODS) showed † Merely because of cost, we initially utilized relatively inexpensive, reusable cDNA nylon micorarray products (Atlas™ Array, Clontech Laboratories, Inc., Palo Alto, CA 94303) spotted with 588 murine gene elements. (19) We switched recently to a more expensive microarray (GeneChip®, Affymetrix, Inc., Santa Clara, CA 95051) that affords more comprehensive murine and human genomic screening and better signal to noise ratios (see The Promise of Genomics). 
FIG. 2. Splenic response to injury, Patients 1 (injury without MODS) and 2 (injury with MODS).
A, Photomicrograph of tissue section stained with H & E. The differences identified are at the phenotypic level (the "biome" in the parlance of genomics) and are discernible with the aid of a microscope B, Microarray GeneChip® image files from the same specimens. The level of biological resolution has changed to mRNA (the transcriptome). Visual comparisons between the images are not useful; computer-assisted analysis is required (see Table 4 and Fig. 3) . See text for additional details. evidence of increased lymphocyte apoptosis, substantially decreased lymphocyte populations, neutrophil infiltration, and erythroid precursors, consistent with our previous reports ( Table 4 . Compared to the spleen from Patient 1 without MODS, the spleen from Patient 2 with MODS had a 10-to 20-fold decrease in relative mRNA abundance for some of the CD proteins and receptors for T and B lymphocytes, and a 15-fold decrease in abundance for IL-7 receptor, among others. In contrast, Patient 2's spleen (MODS) showed marked increases in message for non-lymphocyte genes, including neutrophil elastase and myeloperoxidase. A visual comparative analysis (Fig. 3) shows the log-transformed expression levels of Patients 1 and 2 for 5,062 genes whose untransformed expression levels were greater than zero. Given the sample size of only 2 patients, major limitations to this type of analysis (including differences in tissue sampling site, tissue type, time of harvest, and cell population heterogeneity) cannot be overcome. What conclusions, then, can be drawn from these very limited data? Merely that they serve as a genomic "proof-of-principle," indicating the feasibility of our investigative approach. We cannot help noticing, however, that these findings are consistent with our emerging immunological descriptions of the host's response to injury. Specifically, severe injury is associated longitudinally with a marked decrease in the splenic populations of lymphocytes and a decrease in the expression of genes for resting and activated T and B-cells (16) .
As seen on the left side of Figure 2 , the more traditional "snapshot" of the splenic response to injury is based upon changes in cell type, number, and morphology (H & E stain, phenotype). In contrast, the microarray data on the right side of the figure tell the same story, but at a different level of resolution namely, the changes in gene expression (GeneChip® transcriptome, see also Table 4 ). The two pictures and the information they convey are synergistic and complementary (refer also to Fig. 1 ).
FUTURE DIRECTIONS: THE NEED FOR COLLABORATION
In summary, the complexity of the response to injury has been viewed, until recently, from the perspective of only one or a few genes operating at a time. With the progress evident in genomics described herein, it will soon be possible to examine the activity of all human or rodent genes simultaneously. Attempts to relate changes in transcription and translation to key investigational questions relevant to surgery, trauma, wound healing, and sepsis will follow. A key tool in these endeavors will be microarray technology. In addition to gene expression profiling, microarrays can also be used for genotyping and detection of single nucleotide polymorphisms (SNPs) (4). Rapid, highly parallel detection of SNPs that alter immunity will help predict the likelihood of exaggerated or insufficient immune responses following injury (17) . Likewise, determination of the molecular "fingerprint" of leukocyte genes activated by specific pathogens is expected to allow prompt recognition of invading organisms and probably earlier treatment than would be possible using other means of detection (e.g., blood cultures).
A number of potential limitations remain in applying the genomic approach to injury in addition to those described above (see also Table 2 ). For example, it is anticipated that patterns of gene expression as determined by expression profiling at a single point in time will be highly predictive of future events in critically ill or injured patients. However, this "snapshot" may not be adequate in the dynamic setting of rapidly progressive shock. Instead, longitudinal collection of expression data may be required, but this will be cumbersome and expensive. Moreover, it is not clear that expression profiling of circulating leukocytes will provide sufficient insight into the nature of immune activation or its relationship to injury in organs of interest (e.g., lung, heart, kidney, and intestine). Longitudinal sampling of these tissues in patients is simply not feasible, leaving the question of the relevance of leukocyte compartmentalization unanswered, at least for the moment. Overlaying the scatterplot are three ellipses containing (from the inner ellipse to the outer ellipse) 90%, 95%, and 99% of the data points. One reasonable analytic approach we are investigating is to examine sets of genes outside a given confidence ellipse, say the 1% of the genes outside of the 99% confidence ellipse, for their potential association with phenotype (patient outcome). Interesting genes are commonly farthest away from the diagonal, indicating larger differences in mRNA abundance (either increased or decreased) relative to the other patient.
Finally, the field of genomics currently lacks the ability to frame massive amounts of gene expression data in a truly biological (functional) context, for example, integrating changes in gene transcription with SNP (genome) and proteome information.
Because of the extensive expertise required to manage and analyze huge data sets and the current prohibitively high cost of microarrays, efforts to apply genomics to the study of injury are best coordinated by multi-disciplinary groups, as in the example provided above. The Washington University Injury Genomics Group (www.cia.wustl.edu/genomics.html), for instance, provides local investigators with the state-of-the-art tools needed to define the influence of the genome on the host's response to injury at the levels of the transcriptome (and soon, the proteome). Our early profiling results in mice (presented at this year's 23rd Annual Conference on Shock) confirm organ-specific differences in infection-induced patterns of gene expression, implicating regulatory pathways that control apoptosis, cell signaling, and stress-response interactions (18) . Likewise, the multi-institutional Genomics Group of the Trauma Research Network and the Consortium for Expression Profile Studies in Sepsis (CEPSIS, www.cia.wustl.edu/CEPSIS.html) are being organized to link emerging information from the Human and Mouse Genome Projects to our understanding of the pathophysiology of traumatic and septic stimuli. As a direct result of these collaborative efforts, improved diagnostic, therapeutic, and prognostic applications will follow (19) . One had only to witness the excitement and wonder following the announcement of the completion of the human genome "draft" sequence to appreciate the extraordinary potential impact of genomics on our understanding of injury. We have reached the "end of the beginning" (20, 21) .
